Mr Kevin Lehpamer > Clifford Chance > New York, United States > Lawyer Profile

Clifford Chance
31 WEST 52ND STREET
NEW YORK, NY 10019-6131
NEW YORK
United States

Work Department

M&A Corporate, Healthcare, Life Sciences & Chemicals, Private Equity

Position

Kevin Lehpamer focuses on public and private M&A transactions. He regularly advises sellers, purchasers and other parties in negotiated cross-border and domestic mergers, acquisitions, reorganizations, joint ventures and investment transactions.

Kevin has represented a broad range of clients including Ingersoll-Rand, Blackstone, Toshiba, Tyco, Barclays, Owens –Illinois, KKR and JPMorgan.

Lawyer Rankings

United States > M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)

Clifford Chance represents major clients in the private equity sphere including the likes of KKR, Carlyle, Blackstone, and Rothschild in a diverse range of complex and high-value transactions, utilizing an extensive network of experienced attorneys across the US, London, Paris and Frankfurt. Following the departure of former practice head Gary Boss  in June 2022, the New York-based team is jointly led by Kevin Lehpamer and Neil Barlow, the pair having represented Cinven in a $2.6bn agreement with life science giant Bayer AG, acquiring its Environmental Science Professional business. The team is bolstered by the ‘high quality’ David Brinton , who has particular expertise in the energy, infrastructure and financial sectors.